Control of rapid heart rate in patients with atrial fibrillation: Drugs or ablation?

PACE - Pacing and Clinical Electrophysiology

Volumn 19, Issue 3, 1996, Pages 348-356

  Brignole, Michele ^a,c   Menozzi, Carlo ^b  

^a OSPEDALI RIUNITI   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; LABETALOL; SOTALOL; VERAPAMIL;

ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; EXERCISE TOLERANCE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART TAMPONADE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INOTROPISM; LUNG EMBOLISM; MORTALITY; REVIEW; SINUS RHYTHM;

ADRENERGIC BETA-ANTAGONISTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CATHETER ABLATION; DIGOXIN; HEART RATE; HUMANS; TACHYCARDIA;

EID: 0029926337     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1996.tb03337.x     Document Type: Review

References (63)

1. Furberg C, Psaty B, Manolio T, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Heart Study). Am J Cardiol 1994; 74: 236-241.
2. Kannel W, Abbott R, Savage D, et al. Coronary heart disease and atrial fibrillation: The Framingham study. Am Heart J 1983; 106:389-396.
3. Naito M, David D, Michelson EL, et al. The hemodynamic consequences of cardiac arrhythmias: Evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 1983; 106:284-291.
4. Mandel W. Should every patient with atrial fibrillation have the rhythm converted to sinus rhythm? Clin Cardiol 1994; 17:II16-II20.
5. Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease: A cause of reversible heart failure. Am J Med 1949; 7:479-489.
6. Grogan M, Smith H, Gersh B, et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69:1570-1573.
7. Lemery R, Brugada P, Cheriex E, et al. Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol 1987; 60:1406-1408.
8. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: Complete recovery after restoration of sinus rhythm. Am J Med 1988; 85:242-244.
9. Crijns H, Van Gelder I, Van Gilst W, et al. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 1991; 68:335-341.
10. Zehender M, Hohnloser S, Muller B, et al. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: Results of a comparative study and a 2-year follow-up. J Am Coll Cardiol 1992; 19:1054-1059.
11. Hohnloser S. Indications and limitations of class II and III antiarrhythmic drugs in atrial fibrillation. PACE 1994; 17:1019-1025.
12. Antman E, Beamer A, Cantillon C, et al. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: A staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol 1990; 15: 698-707.
13. Wong C, Lau C, Leung W, et al. Usefulness of labetalol in chronic atrial fibrillation. Am J Cardiol 1990; 66:1212-1215.
14. Beasley R, Smith D, McHaffe D. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. Br Med J 1985; 290: 9-11.
15. Lang R, Klein H, Weiss E, et al. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. Chest 1983; 83:491-499.
16. Rawles J, Metcalfe M, Jennings K. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: The effect of digoxin. Br Heart J 1990; 63:225-227.
17. Galun E, Flugelman M, Glikson M, et al. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation. Chest 1991; 99:1038-1040.
18. Zarowitz B, Gheorghiade M. Optimal heart rate control for patients with chronic atrial fibrillation: Are pharmacologic choices truly changing? Am Heart J 1992; 123:1401-1403.
19. Zoble R, Brewington J, Olukotun A, et al. Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation. Am J Cardiol 1987; 60:39D-45D.
20. Roberts S, Diaz C, Nolan P, et al. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. Am J Cardiol 1993; 72:567-573.
21. Roth A, Harrison E, Mitani G, et al. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation 1986; 73:316-324.
22. Lewis R, Lakhani M, Moreland A, et al. A comparison of verapamil and digoxin in the treatment of atrial fibrillation. Eur Heart J 1987; 8:148-153.
23. Lewis R, Laing E, Moreland T, et al. A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation. Eur Heart J 1988; 9: 279-283.
24. Lang R, Klein H, Di Segni E, et al. Verapamil improves exercise capacity in chronic atrial fibrillation: Double-blind crossover study. Am Heart J 1983; 105:820-824.
25. Panidis I, Monganroth J, Baessler C. Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis. Am J Cardiol 1983; 52: 1197-1201.
26. Schwartz J, Keefe D, Kates D, et al. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation. Circulation 1982; 65:1163-1170.
27. Steinberg J, Katz R, Bren G, et al. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise. J Am Coll Cardiol 1987; 9:405-411.
28. Maragno E, Santostasi G, Gaion R, et al. Low- and medium-dose diltiazem in chronic atrial fibrillation: Comparison with digoxin and correlation with drug plasma levels. Am Heart J 1988; 116: 385-392.
29. Lundstrom T, Ryden L. Ventricular rate control and exercise performance in chronic atrial fibrillation: Effects of diltiazem and verapamil. J Am Coll Cardiol 1990; 16:86-90.
30. Atwood E, Myers J, Sullivan M, et al. Diltiazem and exercise performance in patients with chronic atrial fibrillation. Chest 1988; 92:20-25.
31. DiBianco R, Monganroth J, Freitag J, et al. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin. Am Heart J 1984; 108:1121-1127.
32. Atwood E, Sullivan M, Forbes S, et al. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. J Am Coll Cardiol 1987; 10:314-320.
33. Brodsky M, Saini R, Bellinger R, et al. Comparative effects of the combination of digoxin and dl-sotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillation. Am Heart J 1994; 127:572-577.
34. Channer K, Papouchado M, James M, et al. Towards improved control of atrial fibrillation. Eur Heart J 1987; 8:141-147.
35. Packer DL, Bardy GH, Worley SJ, et al. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. Am J Cardiol 1986; 57:563-570.
36. Raeder E, Podrid P, Lown B. Side effects and complications of amiodarone therapy. Am Heart J 1985; 109:975-983.
37. Souza O, Gursoy S, Simonis F, et al. Right-sided versus left-sided radiofrequency ablation of the His bundle. PACE 1992; 15:1454-1459.
38. Trohman R, Simmons T, Moore S, et al. Catheter ablation of the atrioventricular junction using radiofrequency energy and a bilateral cardiac approach. Am J Cardiol 1992; 70:1438-1443.
39. Twidale N, Sutton K, Bartlett L, et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. PACE 1993; 16: 1275-1284.
40. Heinz G, Siostrzonek P, Kreiner G, et al. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug-refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992; 69: 489-492.
41. Kalbfleisch S, Williamson B, Man C, et al. A randomized comparison of the right- and left-sided approaches to ablation of the atrioventricular junction. Am J Cardiol 1993; 72:1406-1410.
42. Menozzi C, Brignole M, Gianfranchi L, et al. Radiofrequency catheter ablation and modulation of atrioventricular conduction in patients with atrial fibrillation. PACE 1994; 17:2143-2149.
43. Kay N, Epstein A, Dailey S, et al. Role of radiofrequency ablation in the management of supraventricular arrhythmias: Experience in 760 consecutive patients. J Cardiovasc Electrophysiol 1993; 4: 371-389.
44. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrio-ventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994; 74:242-246.
45. Rosenquist M, Lee M, Moulinier L, et al. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol 1990; 16:1467-1474.
46. Kay N, Bubien R, Epstein A, et al. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol 1988; 62:741-744.
47. Rodriguez LM, Smeets J, Xie B, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993; 72: 1137-1141.
48. Hindricks G, and MERFS investigators. The Multicentre European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 1993; 14:1644-1653.
49. Scheinman M. Patterns of catheter ablation practice in the United States: Results of the 1992 NASPE survey. PACE 1994; 17:873-875.
50. Olgin J, Scheinman M. Catheter ablation of the atrioventricular node for treatment of supraventricular tachyarrhythmias. In DP Zipes, J Jalife (eds.): Cardiac Electrophysiology. From Cell to Bedside. Philadelphia, PA, WB Saunders, 1995, pp. 1453-1460.
51. Evans T, Scheinman M, Zipes D, et al. The percutaneous cardiac mapping and ablation registry: Final summary of results. PACE 1988; 11:1621-1626.
52. Evans T. Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter study. Circulation 1991; 84:1924-1937.
53. Olgin J, Scheinman M. Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol 1993; 21:557-564.
54. Levy S, Bru P, Aliot E, et al. Long-term follow-up of atrioventricular ablation. PACE 1988; 11: 1149-1153.
55. Sadoul N, de Chillou C, Lamouri F, et al. Results, complications and long-term outcome of percutaneous ablation of atrioventricular conduction: A series of 85 cases. Arch Mal Coeur 1994; 87: 1453-1458.
56. Carson P, Jonhson G, Dunkman B, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT studies. Circulation 1993; 87:VI102-VI110.
57. Duckeck W, Engelstein E, Kuck KH. Radiofrequency current therapy in atrial tachyarrhythmias: Modulation versus ablation of atrioventricular nodal conduction. PACE 1993; 16:629-636.
58. Fleck P, Chen PS, Boyce K, et al. Radiofrequency modification of atrioventricular conduction by selective ablation of the low posterior septal right atrium in a patient with atrial fibrillation and a rapid ventricular response. PACE 1993; 16: 377-381.
59. Williamson B, Ching Man K, Daoud E, et al. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994; 331: 910-917.
60. Feld G, Fleck P, Fujimura O, et al. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. Circulation 1994; 90:2299-2307.
61. Brignole M, Menozzi C, Gianfranchi L, et al. Single-session step-wise radiofrequency catheter modification of atrioventricular conduction in patients with paroxysmal atrial fibrillation. Eur JCPE 1995; 5:18-22.
62. Blanck Z, Dhala A, Sra J, et al. Characterization of atrioventricular nodal behavior and ventricular response during atrial fibrillation before and after a selective slow-pathway ablation. Circulation 1995; 91:1086-1094.
63. Della Bella P, Carbucicchio C, Tondo C, et al. Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter. J Am Coll Cardiol 1995; 25:39-46.